These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 23126536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
    Hwang EC, Jung SI, Lee HJ, Lee JJ, Kwon DD.
    Int Braz J Urol; 2017; 43(4):615-627. PubMed ID: 28266813
    [Abstract] [Full Text] [Related]

  • 3. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
    Yang DH, Kim MH, Lee YK, Hong CY, Lee HJ, Nguyen-Pham TN, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ.
    Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188
    [Abstract] [Full Text] [Related]

  • 4. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
    Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ.
    Ann Hematol; 2010 Aug; 89(8):795-801. PubMed ID: 20238114
    [Abstract] [Full Text] [Related]

  • 5. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM.
    Vaccine; 2008 Jun 02; 26(23):2824-32. PubMed ID: 18450338
    [Abstract] [Full Text] [Related]

  • 6. Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
    Wieckowski E, Chatta GS, Mailliard RM, Gooding W, Palucka K, Banchereau J, Kalinski P.
    Prostate; 2011 Feb 01; 71(2):125-33. PubMed ID: 20717900
    [Abstract] [Full Text] [Related]

  • 7. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
    Hansen M, Hjortø GM, Donia M, Met Ö, Larsen NB, Andersen MH, thor Straten P, Svane IM.
    Vaccine; 2013 Jan 11; 31(4):639-46. PubMed ID: 23200882
    [Abstract] [Full Text] [Related]

  • 8. Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.
    Park MH, Yang DH, Kim MH, Jang JH, Jang YY, Lee YK, Jin CJ, Pham TN, Thi TA, Lim MS, Lee HJ, Hong CY, Yoon JH, Lee JJ.
    Cancer Res Treat; 2011 Mar 11; 43(1):56-66. PubMed ID: 21509164
    [Abstract] [Full Text] [Related]

  • 9. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G.
    Br J Cancer; 2001 Nov 30; 85(11):1722-30. PubMed ID: 11742494
    [Abstract] [Full Text] [Related]

  • 10. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I, Hesse A, Schunder T, Kämpgen E, Brenner MK, Schuler G, Steinkasserer A, Nettelbeck DM.
    J Immunother; 2009 Jun 30; 32(5):524-38. PubMed ID: 19609245
    [Abstract] [Full Text] [Related]

  • 11. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H.
    Int J Oncol; 2006 Sep 30; 29(3):531-9. PubMed ID: 16865268
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 30; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 13. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ, Turtle CJ, Kassianos AJ, Hart DN.
    J Immunother; 2006 Dec 30; 29(6):596-605. PubMed ID: 17063122
    [Abstract] [Full Text] [Related]

  • 14. Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens.
    Turkeri L, Onol FF, Ozyurek M.
    Urol Oncol; 2010 Dec 30; 28(3):290-5. PubMed ID: 19362861
    [Abstract] [Full Text] [Related]

  • 15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 30; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 16. [Induction of prostate cancer-specific CTLs with dendritic cells pulsed by different types of tumor antigens].
    Xue S, Sun YH, Gao JP, Xu XF, Zhang ZY, Xu CL, Zhu XJ, Fan ZF.
    Zhonghua Nan Ke Xue; 2010 May 30; 16(5):410-4. PubMed ID: 20684320
    [Abstract] [Full Text] [Related]

  • 17. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
    Onaitis MW, Kalady MF, Emani S, Abdel-Wahab Z, Tyler DS, Pruitt SK.
    Surgery; 2003 Aug 30; 134(2):300-5. PubMed ID: 12947333
    [Abstract] [Full Text] [Related]

  • 18. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
    Hong CY, Kim SY, Lee HJ, Lee SE, Lim SC, Rhee JH, Lee JJ.
    J Immunother; 2014 Jan 30; 37(1):16-25. PubMed ID: 24316552
    [Abstract] [Full Text] [Related]

  • 19. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
    Zhou CJ, Ma W, Zhou JD, Zhao YX, Xie HQ.
    Ai Zheng; 2006 Feb 30; 25(2):143-7. PubMed ID: 16480575
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
    Zhang Y, Ma B, Zhou Y, Zhang M, Qiu X, Sui Y, Zhang X, Ma B, Fan Q.
    Breast Cancer Res Treat; 2007 Nov 30; 105(3):277-86. PubMed ID: 17187233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.